Showing results (1971-1980 of 3,531) with videos related to

Sort By:
Pageof 354
Thoracic Cancer|October 21, 2021
Synchronous microwave ablation followed by core-needle biopsy via a coaxial cannula for highly suspected malignant lung ground-glass opacities: A single-center, single-arm retrospective studyFanLei Kong, ZhiXin Bie, YuanMing Li, et al.
Thoracic Cancer|October 24, 2021
Successful treatment of locally advanced lung cancer using late concurrent chemoradiation therapy administered after immune checkpoint inhibitor plus platinum chemotherapyTaichi Matsubara, Shinkichi Takamori, Takatoshi Fujishita, et al.
Thoracic Cancer|October 14, 2021
Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factorsChao Zhu, Jialin Ding, Songping Wang, et al.
Thoracic Cancer|October 2, 2021
Prognostic implication of erector spinae muscles in non-small-cell lung cancer patients treated with immuno-oncology combinatorial chemotherapyTaisuke Araki, Yoshiaki Kitaguchi, Yusuke Suzuki, et al.
Thoracic Cancer|October 27, 2021
Response and safety of whole-brain radiotherapy plus temozolomide for patients with brain metastases of non-small-cell lung cancer: A meta-analysisJianguo Han, Ming Qiu, Li Su, et al.
Thoracic Cancer|October 25, 2021
Risk factors for surgical complications after anatomic lung resections in the era of VATS and ERASChristian Galata, Ioannis Karampinis, Eric D Roessner, et al.
Thoracic Cancer|October 19, 2019
CD137 ligand feedback upregulates PD-L1 expression on lung cancer via T cell production of IFN-γHelin Wang, Zhuohong Yan, Jianqing Hao, et al.
Thoracic Cancer|July 12, 2022
Investigation on the incidence and risk factors of lung cancer among Chinese hospital employeesZi-Hao Chen, Zhi-Yong Chen, Jing Kang, et al.
Thoracic Cancer|July 12, 2022
High expression of fibroblast-activating protein is a prognostic marker in non-small cell lung carcinomaNaoki Yanagawa, Mayu Sugai, Shunsuke Shikanai, et al.
Thoracic Cancer|July 9, 2022
Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-disease small cell lung cancer: protocol of ACIST studyKazumasa Akagi, Hirokazu Taniguchi, Minoru Fukuda, et al.
Pageof 354